FIELD: medicine. SUBSTANCE: aethimizol is proposed to use as agent decreasing blood coagulability. EFFECT: increased effectiveness of agent. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING GLOMERULONEPHRITIS | 1996 |
|
RU2141857C1 |
| METHOD FOR PREVENTING THROMBOGENIC COMPLICATIONS AFTER PROLONGED ABDOMINAL OPERATIONS | 1999 |
|
RU2169569C2 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY OF PATIENTS AFFECTED WITH ISCHEMIC HEART DISEASE | 1994 |
|
RU2082977C1 |
| HYPERFIBRINOLYSIS PREDICTION AND DIAGNOSTIC TECHNIQUE | 2007 |
|
RU2358657C2 |
| AGENT SHOWING ANTICOAGULATING ACTIVITY | 1994 |
|
RU2085205C1 |
| ANTICOAGULANT | 1995 |
|
RU2068702C1 |
| METHOD FOR TREATMENT OF ANAEROBIC INFECTION IN LIMB INJURIES | 1990 |
|
RU2008813C1 |
| METHOD OF DIAGNOSING SYNDROME OF DISSEMINATED INTRAVASCULAR BLOOD COAGULATION | 1992 |
|
RU2033611C1 |
| METHOD OF TREATING ACUTE VENOUS THROMBOSES OF VARIOUS LOCALISATIONS WITH UNDERLYING HEMORRHAGIC COMPLICATIONS | 2012 |
|
RU2477636C1 |
| AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
